Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blocking CTCs and Neutrophils Could Prevent Cancer Metastasis

By LabMedica International staff writers
Posted on 21 Feb 2019
A mechanism has been proposed that explains why the association of circulating tumor cells (CTCs) and immune neutrophils enhances the ability of the cancer cells to form metastases.

CTCs are precursors of metastasis in several types of cancer and are occasionally found within the bloodstream in association with non-malignant cells such as white blood cells (WBCs). More...
The identity and function of these CTC-associated WBCs, as well as the molecular features that define the interaction between WBCs and CTCs, has been poorly defined.

To help clarify the nature of this interaction, investigators at the University of Basel (Switzerland) isolated and characterized individual CTC-associated WBCs, as well as corresponding cancer cells within each CTC–WBC cluster, from patients with breast cancer and from mouse models. They used single-cell RNA sequencing to show that in the majority of these cases, CTCs were associated with neutrophils.

The investigators reported in the February 6, 2019, online edition of the journal Nature that by comparing the transcriptome profiles of CTCs associated with neutrophils against those of CTCs alone, they detected a number of differentially expressed genes that outlined cell cycle progression, leading to more efficient metastasis formation. Furthermore, they identified cell–cell junction and cytokine–receptor pairs that defined CTC–neutrophil clusters, representing key vulnerabilities of the metastatic process.

The investigators concluded that the association between neutrophils and CTCs drove cell cycle progression within the bloodstream and expanded the metastatic potential of CTCs, which provides a rationale for targeting this interaction in treatment of breast cancer.

"Surprising is that the patient's own neutrophils act by protecting CTCs in circulation, allowing CTCs to more efficiently seed metastasis", said senior author Dr. Nicola Aceto, assistant professor of oncology at the University of Basel. "We undertook a number of experiments to fully characterize CTC-neutrophil clusters from patients and mouse models, aiming to find strategies to suppress their ability to form metastasis. Indeed, the presence of CTC-neutrophil clusters in the bloodstream also correlates with a poor prognosis of breast cancer patients."

Related Links:
University of Basel


New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Portable Electronic Pipette
Mini 96
Laboratory Software
ArtelWare
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.